Advances of imaging for hepatocellular carcinoma

Oncology

Volumn 78, Issue SUPPL. 1, 2010, Pages 46-52

  Choi, Byung Ihn ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

Computed tomography; Contrast agent; Diffusion MR; Elastography; Hepatocellular carcinoma; Liver tumors; Magnetic resonance imaging; Perfusion CT; Ultrasonography

Indexed keywords

ANGIOGRAPHY; ARTIFACT; CANCER DIAGNOSIS; CHRONIC LIVER DISEASE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; ECHOGRAPHY; ELASTOGRAPHY; HUMAN; LIVER CELL CARCINOMA; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW;

CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; DIAGNOSTIC IMAGING; HUMANS; LIVER NEOPLASMS;

EID: 77954494405     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000315230     Document Type: Review

References (29)

1. Choi BI: The current status of imaging diagnosis of hepatocellular carcinoma. Liver Transplant 2004; 10:S20-S25.
2. Bruix J, Sherman M: Management of hepatocellular carcinoma. Practice Guidelines Committee, American Association for the Study of Liver Diseases. Hepatology 2005; 42: 1208-1236.
3. Wilson SR, Burns PN: An algorithm for the diagnosis of focal liver masses using microbubble contrast-enhanced pulse-inversion sonography. AJR Am J Roentgenol 2006; 186: 1401-1412.
4. Kim TK, Jang HJ, Burns PN, Murphy-Lavallee J, Wilson SR: Focal nodular hyperplasia and hepatic adenoma: differentiation with low-mechanical-index contrast-enhanced sonography. AJR Am J Roentgenol 2008; 190: 58-66.
5. Hatanaka K, Kudo M, Minami Y, Ueda T, Tatsumi C, Kitai S, Takahashi S, Inoue T, Hagiwara S, Chung H, Ueshima K, Maekawa K: Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid. Intervirology 2008; 51:S61-S69.
6. Itoh A, Ueno E, Tohno E, Kamma H, Takahashi H, Shiina T, Yamakawa M, Matsumura T: Breast disease: clinical application of US elastography for diagnosis. Radiology 2006; 239: 341-350.
7. Fahey BJ, Nelson RC, Bradway DP, Hsu SJ, Dumont DM, Trahey GE: In vivo visualization of abdominal malignancies with acoustic radiation force elastography. Phys Med Biol 2008; 53: 279-293.
8. Murakami T, Kim T, Takahashi S, Nakamura H: Hepatocellular carcinoma: multidetector row helical CT. Abdom Imaging 2002; 27: 139-146.
9. Yeh BM, Shepherd JA, Wang ZJ, Teh HS, Hartman RP, Prevrhal S: Dual-energy and low-kVp CT in the abdomen. AJR Am J Roentgenol 2009; 193: 47-54.
10. Kambadakone AR, Sahani DV: Body perfusion CT: technique, clinical applications, and advances. Radiol Clin N Am 2009; 47: 161-178.
11. Sahani DV, Holalkere NS, Mueller PR, Zhu AX: Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue-initial experience. Radiology 2007; 243: 736-743.
12. Ippolito D, Sironi S, Pozzi M, Antolini L, Ratti L, Alberzoni C, Leone EB, Meloni F, Valsecchi MG, Fazio F: Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization. Acad Radiol 2008; 15: 919-927.
13. Kan Z, Kobayashi S, Phongkitkarun S, Charnsangavej C: Functional CT quantification of tumor perfusion after transhepatic arterial embolization in a rat model. Radiology 2005; 237: 144-150. (Pubitemid 41346158)
14. Zhu AX, Holalkere NS, Muzikansky A, Horgan K, Sahani DV: Early antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma. Oncology 2008; 13: 120-125.
15. Kim KW, Lee JM, Klotz E, Park HS, Lee DH, Kim JY, Kim SJ, Kim SH, Lee JY, Han JK, Choi BI: Quantitative CT color mapping of the arterial enhancement fraction of the liver to detect hepatocellular carcinoma. Radiology 2009; 250: 425-434.
16. Hayashi M, Matsui O, Ueda K, Kawamori Y, Kadoya M, Yoshikawa J, Gabata T, Takashima T, Nonomura A, Nakanuma Y: Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. AJR Am J Roentgenol 1999; 172: 969-976.
17. Lee DH, Kim SH, Lee JM, Park HS, Lee JY, Yi NJ, Suh KS, Jang JJ, Han JK, Choi BI: Diagnostic performance of multidetector row computed tomography, superparamagnetic iron oxide-enhanced magnetic resonance imaging, and dual-contrast magnetic resonance imaging in predicting the appro priateness of a transplant recipient based on Milan criteria: correlation with histopathological findings. Invest Radiol 2009; 44: 311-321.
18. Kim SH, Choi D, Kim SH, Lim JH, Lee WJ, Kim MJ, Lim HK, Lee SJ: Ferucarbotran-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol 2005; 184: 1069-1076.
19. Kim YK, Kwak HS, Kim CS, Chung GH, Han YM, Lee JM: Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO-enhanced MR imaging and 16-detector row CT. Radiology 2006; 238: 531-541.
20. Choi SH, Lee JM, Yu NC, Suh KS, Jang JJ, Kim SH, Choi BI: Hepatocellular carcinoma in liver transplantation candidates: detection with gadobenate dimeglumine-enhanced MRI. AJR Am J Roentgenol 2008; 191: 529-536.
21. Park HS, Lee JM, Kim SH, Chang S, Kim SJ, Han JK, Choi BI: Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: value of SPIO-enhanced MR imaging at 3.0 Tesla. J Magn Reson Imaging 2009; 29: 328-335.
22. Jung G, Breuer J, Poll LW, Koch JA, Balzer T, Chang S, Mödder U: Imaging characteristics of hepatocellular carcinoma using the hepatobiliary contrast agent Gd-EOB-DTPA. Acta Radiol 2006; 47: 15-23.
23. Bartolozzi C, Crocetti L, Lencioni R, Cioni D, Della Pina C, Campani D: Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissuespecific MR contrast media. Eur Radiol 2007; 17: 2519-2530.
24. Hammerstingl R, Huppertz A, Breuer J, et al: Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesion. Eur Radiol 2008; 18: 457-467.
25. Kim SH, Kim SH, Lee J, Kim MJ, Jeon YH, Park Y, Choi D, Lee WJ, Lim HK: Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol 2009; 192: 1675-1681.
26. Taouli B, Ehman RL, Reeder SB: Advanced MRI methods for assessment of chronic liver disease. AJR Am J Roentgenol 2009; 193: 14-27.
27. Zech CJ, Reiser MF, Herrmann KA: Imaging of hepatocellular carcinoma by computed tomography and magnetic resonance imaging: state of the art. Dig Dis 2009; 27: 114-124.
28. Kamel IR, Liapi E, Reyes DK, Zahurak M, Bluemke DA, Geschwind JF: Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging. Radiology 2009; 250: 466-473.
29. Venkatesh SK, Yin M, Glockner JF, Takahashi N, Araoz PA, Talwalkar JA, Ehman RL: MR elastography of liver tumors: preliminary results. AJR Am J Roentgenol 2008; 190: 1534-1540.